J&J's one-shot Covid vaccine is safe and generates promising immune response in early trial

Jan 14, 2021 , CNBC Health
The new clinical trial data shows a single shot of the vaccine "gives sustainable antibodies," Dr. Paul Stoffels, J&J chief scientific officer, told CNBC.

Read the full story...

Trending healthcare news keywords at this moment

cancer covid study vaccine covid-